Immunoprecipitation of whole-cell lysates with an antiserum against SMYD3 or RPB1, followed by immunoblotting, revealed that SMYD3 is a molecular partner of RPB1 in CRC and GC cells (Figs. 3E, 4, and Appendix Fig. S2). Here, SMYD3 is linked to colorectal carcinoma.